Zuellig Pharma 擴大與靈北的合作，支持神經精神健康解決方案的商業化
This expanded partnership is crucial for improving access to specialized neuro-psychiatric treatments across Asia, a region with significant unmet needs in mental health.
Expanded partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in Asia.
Zuellig Pharma 扩大了与灵北的合作，以加强其在亚洲的神经精神健康解决方案的商业化。此次合作将利用 Zuellig Pharma 广泛的分销网络和市场专业知识，将针对神经和精神疾病的创新疗法带给更广泛的患者群体。此次扩大的合作旨在改善该地区对专业医疗解决方案的可及性。
This expanded partnership is crucial for improving access to specialized neuro-psychiatric treatments across Asia, a region with significant unmet needs in mental health. By combining Lundbeck's innovative therapies with Zuellig Pharma's robust commercialization capabilities, more patients will benefit from advanced healthcare solutions, addressing a critical public health challenge and fostering better patient outcomes.
The expanded partnership directly addresses the growing need for neuro-psychiatric health solutions in APAC, leveraging Zuellig Pharma's regional reach to improve access to specialized treatments for a significant patient population.
Where this signal fits in the broader landscape.
https://www.zuelligpharma.com/news-insights/Zuellig-Pharma-expands-partnership-with-Lundbeck-to-support-commercialization-of-neuro-psychiatric-health-solutions-in-Asia
Read Full SourceGet curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
Sign in to save notes on signals.
登录